+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Biosimilar"

From
Ranibizumab Drugs & Biosimilars Market - Global Forecast 2026-2032 - Product Thumbnail Image

Ranibizumab Drugs & Biosimilars Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 198 Pages
  • Global
From
Monoclonal Antibodies Market - Global Forecast 2026-2032 - Product Thumbnail Image

Monoclonal Antibodies Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 193 Pages
  • Global
From
Antibody Therapeutics Market - Global Forecast 2026-2032 - Product Thumbnail Image

Antibody Therapeutics Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 191 Pages
  • Global
From
Biopharmaceuticals Market - Global Forecast 2026-2032 - Product Thumbnail Image

Biopharmaceuticals Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 188 Pages
  • Global
From
Recombinant Uricase Market - Global Forecast 2026-2032 - Product Thumbnail Image

Recombinant Uricase Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 192 Pages
  • Global
From
From
From
From
From
From
From
Loading Indicator

The Biosimilar market is a subset of the biotechnology industry that focuses on the development and production of biologic drugs that are similar to existing biologic drugs. Biosimilars are created using a process called recombinant DNA technology, which involves the manipulation of genetic material to create a drug that is similar to an existing biologic drug. Biosimilars are typically used to treat chronic conditions such as cancer, rheumatoid arthritis, and multiple sclerosis. Biosimilars are typically cheaper than their brand-name counterparts, making them an attractive option for patients and healthcare providers. Some companies in the Biosimilar market include Amgen, Biocon, Celltrion, Dr. Reddy's Laboratories, Mylan, Pfizer, Sandoz, and Teva Pharmaceuticals. Show Less Read more